KWA
NUVB icon

Kingswood Wealth Advisors’s Nuvation Bio NUVB Stock Holding History

Kingswood Wealth Advisors’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$197K Buy
34,660
+8,075
+30% +$39.5K 0.01% 952
2026
Q1 		$114K Buy
26,585
+3,914
+17% +$21.8K 0.01% 906
2025
Q4 		$203K Buy
22,671
+941
+4% +$5.83K 0.01% 824
2025
Q3 		$80.4K Hold
21,730
– – ﹤0.01% 785
2025
Q2 		$42.4K Buy
+21,730
New +$45.3K ﹤0.01% 738

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Kingswood Wealth Advisors's NUVB Position: Q2 2026 in Review

Kingswood Wealth Advisors increased its Nuvation Bio (NUVB) stake by 30% in Q2 2026, buying an estimated $39.5K and bringing the position to 34,660 shares worth $197K. The position accounts for 0.01% of the portfolio, ranked #952.

Kingswood Wealth Advisors first reported a position in NUVB in Q2 2025 and has held it in 5 quarters since. The position peaked at $203K in Q4 2025. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Kingswood Wealth Advisors held 34,660 shares of Nuvation Bio worth $197K as of Q2 2026.
  • Kingswood Wealth Advisors bought 8,075 Nuvation Bio shares in Q2 2026, an estimated $39.5K.
  • Nuvation Bio made up 0.01% of Kingswood Wealth Advisors's portfolio in Q2 2026, its #952 holding.
  • Kingswood Wealth Advisors first reported a position in Nuvation Bio in Q2 2025 and has held it in 5 quarters since.
  • Kingswood Wealth Advisors's Nuvation Bio position peaked at $203K in Q4 2025.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Kingswood Wealth Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.